Covidien Receives FDA Clearance to Market Single-Incision Laparoscopic Surgery

139
A leading global provider of healthcare products, announced that its Surgical Devices business unit has received FDA 510(k) clearance to market the Covidien SILS(TM) Procedure Kit, indicated for Single-Incision Laparoscopic Surgery and other advanced laparoscopic procedures.

A leading global provider of healthcare products, announced that its Surgical Devices business unit has received FDA 510(k) clearance to market the Covidien SILS(TM) Procedure Kit, indicated for Single-Incision Laparoscopic Surgery and other advanced laparoscopic procedures.
The devices in the kit can be used by surgeons to conveniently perform laparoscopic procedures. The kit features several advanced articulating instruments and access ports, which enable improved access to the surgical site and maneuverability for tissue dissection and retraction.

Scott Flora, President, Surgical Devices, Covidien said,  introduction of products for SILS(TM) is an important step toward our ultimate goal of enabling incision-less surgery that will improve patient outcomes . First surgical revolution with multi-port laparoscopic surgery, and we are innovators once again with SILS(TM), which offers surgeons an immediate advancement in patient care by minimizing scarring and pain.

Covidien is actively working with surgeons around the world to develop even less invasive approaches for surgery, including Natural Orifice Transluminal Endoscopic Surgery (NOTES) performed through the body's natural orifices.